Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zemuron in Pediatric and Adolescent Anesthesia
NCT00124735Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Oct 2004
- Primary completion
- Aug 2007
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of rocuronium in Anesthesia (2 arms), sponsored by Merck & Co. Primary endpoint: Total Dose of Zemuron (Rocuronium) Administered. Started Oct 2004; status: completed.
02
Drugs
rocuronium
03
Conditions
Anesthesia
Beyond the preview
Go deeper on NCT00124735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00124735.